I expect the price of Sanofi to carry on falling inside the descending channel, especially if global market consolidates due to rising inflation fears. Sanofi has not been able to produce a covid vaccine and is just starting phase I/II trials for a second vaccine candidate which leaves the near future a bit blurry and may keep investors away. Once the price has reached the bottom of the horizontal range (64 EUR) I expect a reversal for a new bullish trend towards 95EUR by end of 2022.